Keyphrases
Hypoxia-inducible factor-1α (HIF-1α)
100%
NADPH Oxidase
100%
Cardiac Dysfunction
100%
Pulmonary Hypertension
100%
Glucocorticoid Excess
100%
Cardiovascular Effects
37%
P22phox
37%
Reactive Oxygen Species
25%
Cardiovascular System
25%
Glucocorticoid Therapy
25%
Pulmonary Vascular Remodeling
25%
Transcription Factor
12%
Cardiovascular Disease
12%
Gene Coding
12%
Angiogenesis
12%
Reactive Oxygen Species Production
12%
Reactive Oxygen Species Signaling
12%
Cardiac Hypertrophy
12%
Chronic Treatment
12%
Left Ventricular Dysfunction
12%
Cardiovascular Pathology
12%
Synthetic Glucocorticoids
12%
Systemic Glucocorticoids
12%
HIF-1 Signaling Pathway
12%
Systemic Hypertension
12%
Vascular Proliferation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Glucocorticoid
100%
Hypoxia Inducible Factor 1
100%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
100%
Pulmonary Hypertension
100%
Dexamethasone
62%
Mouse
50%
Reactive Oxygen Metabolite
50%
Side Effect
37%
Vascular Remodeling
25%
Cardiovascular Disease
12%
Heart Ventricle Hypertrophy
12%
Heart Left Ventricle Failure
12%
Transcription Factors
12%
Hypertension
12%
Biochemistry, Genetics and Molecular Biology
Glucocorticoid
100%
NAD(P)H Oxidase
100%
Hypoxia Inducible Factor 1
100%
Dexamethasone
62%
Mouse
50%
P22phox
37%
Factor I Deficiency
12%
Low Drug Dose
12%
Heart Ventricle Function
12%
Transcription Factors
12%
Angiogenesis
12%